Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARTL | AMGN | BMY | GILD | ILMN |
| Company | Artelo Biosciences Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.3000 | 273.45 | 47.39 | 67.47 | 121.97 |
| High | 1.3642 | 274.35 | 47.50 | 67.90 | 122.04 |
| Low | 1.3000 | 267.24 | 44.37 | 65.09 | 116.91 |
| Last | 1.3400 | 269.38 | 44.70 | 65.27 | 121.05 |
| Change | -0.0018 | -3.63 | -4.16 | -1.81 | -1.82 |
| % Change | -0.13% | -1.33% | -8.51% | -2.70% | -1.48% |
| Volume | 5,200 | 1,794,000 | 45,069,000 | 15,171,900 | 962,700 |
| 20-Day Average Volume | 8,890 | 2,149,590 | 12,858,680 | 6,861,755 | 1,516,055 |
| Previous Close | 1.3418 | 273.01 | 48.86 | 67.08 | 122.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4511 | 270.70 | 49.94 | 68.68 | 125.63 |
| 20-Day Raw Stochastic | 25.72% | 31.20% | 3.27% | 2.05% | 21.86% |
| 20-Day Relative Strength | 41.30% | 44.80% | 28.31% | 28.32% | 42.06% |
| Weighted Alpha | -21.88 | +9.12 | -34.75 | -23.73 | -38.55 |
| Today's Opinion | 72% Sell | 72% Sell | 88% Sell | 100% Sell | 88% Sell |
| Previous Opinion | 56% Sell | 40% Sell | 88% Sell | 100% Sell | 88% Sell |
| Last Month's Opinion | 16% Sell | 24% Buy | 8% Sell | 88% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.69% since 04/18/24 | +2.52% since 04/18/24 | -7.45% since 04/18/24 | -1.35% since 04/18/24 | +3.74% since 04/18/24 |
| Low | 1.2600 on 04/23/24 | 260.68 on 04/19/24 | 44.37 on 04/25/24 | 65.09 on 04/25/24 | 116.61 on 04/19/24 |
| High | 1.3900 on 04/19/24 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.90 on 04/25/24 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | -11.00% since 03/25/24 | -4.07% since 03/25/24 | -14.45% since 03/25/24 | -10.07% since 03/25/24 | -9.70% since 03/25/24 |
| Low | 1.2500 on 04/18/24 | 260.68 on 04/19/24 | 44.37 on 04/25/24 | 65.09 on 04/25/24 | 115.73 on 04/18/24 |
| High | 1.5999 on 04/09/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | -2.19% since 01/25/24 | -13.18% since 01/25/24 | -9.90% since 01/25/24 | -18.65% since 01/25/24 | -15.21% since 01/25/24 |
| Low | 1.2500 on 04/18/24 | 260.68 on 04/19/24 | 44.37 on 04/25/24 | 65.09 on 04/25/24 | 115.73 on 04/18/24 |
| High | 1.7500 on 02/14/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 80.51 on 01/26/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -6.29% since 10/25/23 | -1.02% since 10/25/23 | -21.04% since 10/25/23 | -16.74% since 10/25/23 | +6.25% since 10/25/23 |
| Low | 1.1500 on 11/20/23 | 249.70 on 10/31/23 | 44.37 on 04/25/24 | 65.09 on 04/25/24 | 89.00 on 11/10/23 |
| High | 1.7500 on 02/14/24 | 329.72 on 02/05/24 | 55.29 on 10/26/23 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,325 | 144,488,960 | 90,596,128 | 81,266,176 | 19,277,818 |
| Shares Outstanding, K | 3,228 | 536,376 | 2,026,759 | 1,245,077 | 159,255 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -9,290,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -3,070,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | -176,000,000 |
| 60-Month Beta | 1.45 | 0.58 | 0.39 | 0.19 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 03/25/24 | 4.71 on 02/06/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 6.51 | 9.98 | 141.23 |